Correlation Engine 2.0
Clear Search sequence regions


  • acids (9)
  • c57bl mice (2)
  • CLA (14)
  • element (3)
  • Fasn (1)
  • fat (6)
  • female (1)
  • lactalbumin (2)
  • Lalba (1)
  • lipogenesis (3)
  • mammals (1)
  • mice (4)
  • milk proteins (3)
  • nuclear proteins (2)
  • Srebf1 (2)
  • sterol (3)
  • Thrsp (2)
  • α lactalbumin (1)
  • Sizes of these terms reflect their relevance to your search.

    Trans-10, cis-12 conjugated linoleic acid (10,12 CLA) is a potent inhibitor of milk fat synthesis in mammals. In the cow, 10 g/d of 10,12 CLA specifically and reversibly inhibits mammary lipogenesis, whereas substantially higher doses are not specific and cause a generalized inhibition of milk synthesis. The objective of this study was to validate a lactating mouse model by establishing the dose response, specificity, and reversibility of the inhibition of milk fat synthesis by 10,12 CLA. Lactating mice (C57BL/6J) received daily doses of 0 (control), 7, 20, or 60 mg of 10,12 CLA for 5 d during established lactation. A second group of lactating mice was treated with 20 mg/d of 10,12 CLA for 4 d and followed post-treatment to evaluate reversibility. CLA decreased pup growth with a 49% decrease occurring with 60 mg/d of CLA. Milk fat percentage was decreased 11% and 20% with the 7 and 20 mg/d dose, respectively, and all CLA treatments had a decreased concentration of de novo synthesized fatty acids (FAs) in milk fat. In agreement, 20 mg/d of 10,12 CLA decreased the lipogenic capacity of mammary tissue by 30% and mammary expression of FA synthase (Fasn), sterol response element binding protein 1 (Srebf1), and thyroid hormone responsive spot 14 (Thrsp) by 30-60%, whereas milk protein percentage and mammary expression of α-lactalbumin (Lalba) were unaltered. This dose of CLA reduced pup growth by nearly 20% and milk de novo synthesized FAs by >35%, and these effects were completely reversed 5 d after 10,12 CLA treatment was terminated. Inhibition of mammary lipogenesis by 10,12 CLA is dose-dependent in the mouse, with a specific and reversible reduction in milk fat synthesis at the 20 mg/d dose and additional nonspecific effects on milk synthesis at higher CLA doses. © 2014 American Society for Nutrition.

    Citation

    Kevin J Harvatine, Megan M Robblee, Stephanie R Thorn, Yves R Boisclair, Dale E Bauman. Trans-10, cis-12 CLA dose-dependently inhibits milk fat synthesis without disruption of lactation in C57BL/6J mice. The Journal of nutrition. 2014 Dec;144(12):1928-34

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 25320189

    View Full Text